Clinical trials involve the use of new therapies, current treatments used in an innovative way, or novel surgical procedures. We provide compassionate and state-of-the-art clinical care for patients with primary and metastatic brain cancers, stroke, and patients and families dealing with quality of life challenges.
Pacific Neuroscience Institute offers advanced and often life changing treatments for patients with primary brain tumors like glioblastoma multiforme, as well as patients with cancers that have metastasized to the brain from primary cancers such as breast, prostate, and melanoma. Studies in other neurologic conditions such as ischemic stroke provide insight into restoring movement and quality of life.
Clinical trials bringing novel therapeutics to patients are conducted through John Wayne Cancer Institute and patients are treated at the neuro-oncology clinics at PNI located at Providence Saint John’s Health Center.
CURRENT CLINICAL TRIALS
Primary Brain Tumor
- Medicenna Therapeutics
- Triphase MRZ-108
- Triphase MRZ-112
- AbbVie / RTOG
- Boehringer Ingelheim
- Orbus Therapeutics
- SanBio / Sunovion: Use of modified stem cells in patients with chronic motor deficit from ischemic stroke
- CancerLife: Mobile digital solution for cancer care and research
- Family caregivers: Exploratory study of caregiver burden
- Inspyr Therapeutics
- National Space Biomedical Research Institute (NSBRI): A study looking at preventing visual impairment in astronauts involved in long duration space flights to the International Space Station